Get Adobe Flash player

Board of Directors

Jan B. Dryselius
Chairman

Jan B. Dryselius is owner of Jan B. Dryselius, CPA, P.C., an tax accounting practice concentrating on individual taxation issues. He is a Member of the Research Conflicts of Interest Committee of the University of Texas Health Science Center at Houston and is prior Chairman of the Board for a publicly traded Swedish corporation, Acrmo, A.B.
Since 1992, Mr. Dryselius has served the Swedish government as Honorary Consul General for the States of Oklahoma, Arkansas, and Texas, excluding the Dallas Metroplex area.

Governor George F. Allen
Director


George F. Allen served the Commonwealth of Virginia for more than 20 years, as Governor, in both bodies of the United States Congress, and as a Delegate holding Thomas Jefferson’s seat in the Virginia General Assembly.

Sworn in as Governor in 1994, George Allen brought sweeping reform that made Virginia a national model in economic development, public safety, education accountability and creative government. As a self-described “Common Sense Jeffersonian Conservative,” Allen pushed through cutting edge reform with bipartisan support. Allen funded the School of Engineering at Virginia Commonwealth University and serves on its Foundation Board of Trustees. He helped found the Appalachian School of Law and serves on its Board of Trustees. Governor Allen also serves as the Virginia Chairman of Communities in Schools.

George Allen has long advocated the safe development of nanotechnology and, in the U.S. Senate, sponsored the 21st Century Nanotechnology Research and Development Act in 2002. He has been a leading proponent for other science innovation initiatives as well.

Elected to the United States Senate in 2000, George Allen advocated policies to make America and Virginia a leader in innovation and technology. In 2001, he was appointed Chairman of the Senate High Tech Task Force and later in his term he created the Competitive Caucus to keep America the “world capital of innovation.” He also founded the Nanotechnology Caucus with Senator Ron Wyden (D-OR). Allen was a member on the Commerce, Science and Transportation Committee, Small Business and Entrepreneurship Committee, the Energy and Natural Resources Committee and Chairman of the Senate Foreign Relations Committee’s Subcommittee on European Affairs.

Currently, George Allen is President of George Allen Strategies, LLC, and serves on the Board of Directors of Lee Technologies. He is Presidential Scholar of the Reagan Ranch for the Young America’s Foundation and is Chairman of the American Energy Freedom Center.

George Allen holds a B.A. degree “with distinction” in History and a law degree from the University of Virginia.

Malcolm Gillis, PhD
Director

Malcolm Gillis, PhD is Past President of Rice University, July 1993-June 2004. Other positions include: Dean of the Faculty of Arts and Sciences, Duke University, July 1991-June 1993; Dean of the Graduate School, Duke University, July 1986-June 1991; Board of Directors, Federal Reserve Bank of Dallas, 1998-2004; National Academy of Sciences Board on Sustainable Development, 1997-2000; Advisory Committee, Oak Ridge National Laboratory (Energy Division) 1984-1987; Board of Trustees, Foundation of Hospital Art, 1989-present; Friends of Education in Chile, 1989-present; Vice Chairman, Cancer Prevention and Research Institute of Texas Oversight Committee, 2008-present.

Harry Bushong
Director, nanoTox president (See Management Team)

Harry Bushong cofounded nanoTox, Inc. in 2005. Prior to nanoTox, Mr. Bushong worked with The Olmsted Group, a New York life sciences merchant bank with a licensed portfolio including Intellectual Property from Columbia University, Wisconsin University, MIT, Vanderbilt and Baylor College of Medicine in the fields of stem cells, genomics, biotech and hepatocytes. Mr. Bushong assisted several companies formed around a proprietary piece of intellectual property, including Omnimmune Corp., Plurion, Zirus (formerly Avatar), and Amphioxus (now Stem Cell Innovations, Inc.) In addition, he worked with both public and private enterprises at Aurora Financial Services, a private NASD broker/dealer focused on the energy sector.

Mr. Bushong formed Wired Capital, a private equity network series, to assist early stage investors identify promising technological and industrial enterprises in Austin, Houston, Chicago, New York, San Francisco and Miami. He also helped transform a solutions management animation company into one of Austin’s earliest streaming media companies, securing three rounds of investments, a $3.5 Million encoding contract, and an international management team to promote the business model.

Richard Wilkens III
Director

Richard Wilkens III is a partner in Transport Facilitator Partners, L.P. and Weather Insight, L.P., which provides tailored weather services to the energy and financial sectors. He co-founded the AR Group and its subsidiaries Air Routing International, Air Security International (ASI Group) and Wilkens Weather Technologies, which were acquired by the communication and aviation electronics solutions company Rockwell Collins in December of 2009. In 1996, Mr. Wilkens was appointed Honorary Consul for the Republic of Slovenia, and he is a member of the Consular Corps of Houston, the third largest consul organization in the U.S. Mr. Wilkens received his Masters of Science in Environmental Health Engineering at the University of Texas at Austin. He received his Bachelors degree in Physics from The University of the South in Sewanee, Tennessee.

John Denson
Director

John Denson is an attorney whose professional experience includes both private and in-house practice, generally focusing on international legal and business matters, and includes the Houston law firm of Baker & Botts; the Singapore and New York City offices of Coudert Brothers, a law firm based in New York City and Paris; in-house experience as Asian Regional Counsel at Michelin Tire Company based in Clermont-Ferrand, France; and as General Counsel of Core Laboratories, a NYSE-listed oil field services company from 1992 to 2008. Upon retirement from Core Laboratories in 2008, he began focusing on the pursuit of ordination as a deacon in the Roman Catholic Church, and has recently opened the law firm of Denson & Tang in Houston, which is affiliated with Hugh Fraser International, an international law firm based in the Middle East. Mr. Denson graduated from the University of Texas School of Law with honors in 1983, after completing both Master’s and Bachelor’s degrees magna cum laude at the University of Texas in Austin. He is currently working on a Masters Degree in Pastoral Studies from St. Mary’s Seminary at the University of St. Thomas in Houston.

Dr. David Sarphie
Director

David Sarphie, CEO of Bio-Nano Consulting Ltd. In London, is a biotechnology entrepreneur with over 13 years experience in project management, senior management and CEO positions within start-up drug-delivery, diagnostics and medical device companies. Prior to his association with the Bio Nano Consulting, Dr Sarphie was CEO of Oxford MediStress, spearheading the founding of the Oxford spin-out developing a novel blood test for stress. He remains an Executive Advisor with the company. Prior to this he was Executive Advisor for BioExec Ventures, a Boston-based biotechnology consultancy. Prior to BioExec Ventures he was CEO of The Acrobot Company, a London-based medical technology start-up, which is developing novel robotic technologies for minimally-invasive orthopaedic surgery. Dr Sarphie developed the initial commercial and development strategies and wrote the business plan for Acrobot, leading a $1.6M equity financing which was completed in September, 2002.

Prior to Acrobot, Dr Sarphie was a co-founder of PowderJect Pharmaceuticals, a UK company focused on developing needle-free drug delivery technologies and a co-inventor of the original technology. While at PowderJect, he was founder and CEO of Progenica Ltd, a PowderJect spin-out company developing novel diagnostic applications of PowderJect® technology. Dr Sarphie created the initial development plan for Progenica, secured the funding from the parent company and spearheaded the clinical assessment of initial product opportunities. Progenica was acquired by Chiron Corporation as part of the acquisition of PowderJect Pharmaceuticals in 2003. Dr. Sarphie holds a D.Phil. in Medical Engineering from Oxford University, an MS in Mechanical Engineering from Stanford University and a BS in Mechanical Engineering from the University of Notre Dame.

 
Welcome To nanoTox

Alternative flash content

You need to upgrade your Flash Player

Get Adobe Flash player

Search Our Site
Published Articles

Fact Sheet for Nanotechnology under the Toxic Substances Control Act | Prevention, Pesticides and Toxics (OPPTS) | US EPA
EPA